Steven Graff-Radford, DDS

Steven B. Graff-Radford, DDS is co-director of The Pain Center at Cedars-Sinai Medical Center and is also an adjunct associate professor at the University of California, Los Angeles (UCLA), Pain Management Center, School of Dentistry.

Dr. Graff-Radford’s research interests include the study of neuropathic facial pain and headache. He has written more than 100 articles, book chapters and scientific abstracts, and he lectures nationally and internationally on the subject of head and neck pain management.

Dr. Graff-Radford has served as president of the Western USA Pain Society and president of the American Board of Orofacial Pain. In addition, he is a past board member of the American Headache Society. He has served on the headache guidelines committee of the Agency for Health Care Policy and Research, and currently serves on the board of and the Trigeminal Neuralgia Association and the American Academy of Orofacial Pain.

Dr. Graff-Radford received his dental degree from the University of Witwatersrand, South Africa. He completed a two-year pain management fellowship at the UCLA Department of Anesthesiology. Following his fellowship, he served as an assistant professor of Anesthesiology and director of education at the UCLA Pain Management Center.

It is the policy of Primary Care Network, Inc. to ensure fair balance, independence, objectivity, scientific rigor, and integrity in all its CME activities. All faculty participating in the programs are expected to disclose to the participants any relationships with commercial companies, those supporting the activity of any others whose products or services may be discussed. The following information is for participants only. It is not assumed that these relationships will have negative impact on the presentations.

Dr. Graff-Radford is a consultant with AstraZeneca, Allergan, Endo, GlaxoSmithKline, Merck & Co., Pfizer, Pharmacia and Ortho McNeil. He is on the speaker’s bureau and has received honoraria from AstraZeneca, Allergan, Elan, Endo, GlaxoSmithKline, Merck & Co, Novartis, Pfizer, Pharmacia and Ortho McNeil. He is also on the advisory board with Allergan, AstraZeneca, Elan, Endo, GlaxoSmithKline, Merck & Co, Pfizer, and Ortho McNeil.

 

Close window